Chronic Obstructive Pulmonary Disease and Weaning From Mechanical Ventilation in Difficult to Wean Patients
NCT ID: NCT00355732
Last Updated: 2006-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
31 (47%) patient with T-tube and 32 (46%) patients with PSV had 2-h trial failure. Of those patients, successful extubation was in 17 (56%) patients with T-tube and in 23 (72%) with PSV (P \<0.001), whereas extubation failure was in 14 (44%) patients with T-tube and in 9 (28%) patients with PSV (P \<0.001). Mechanical ventilation duration was 186.7 h with T-tube and 163.2 h with PSV (P \<0.001), time spent in ICU was 240.7 h with T-tube and 210.2 h with PSV (P \<0.001).
In patients with COPD who failed the 2-h spontaneous breathing trial, based on parameters of procedure outcome, high advantage of PSV method was confirmed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Weaning from mechanical ventilation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* exacerbation of dyspnea \<2 weeks
* signs of respiratory muscle dysfunction
Exclusion Criteria
* age \<18 years
* tracheotomy
* MV duration shorter than 24h
* use of MV on admission to the ICU or transfer to some other ICU for treatment continuation
* patients who died or weaning from MV was discontinued because of another associated disorder
* central nerve system disorders unrelated to hypercapnic encephalopathy or hypoxemia
* cardiac arrest within 5 days
* patients scheduled for organ donation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zagreb
OTHER
Dr. Josip Benčević General Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivo Matić, MD PhD
Role: STUDY_CHAIR
Department of Anesthesiology and Intensive Care, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr. Josip Benčević General Hospital
Slavonski Brod, , Croatia
Clinic Hospital Center Zagreb
Zagreb, , Croatia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
123456
Identifier Type: -
Identifier Source: org_study_id